Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How?

Nancy J. Devlin (), Tianxin Pan, Mark Sculpher, Mark Jit, Elly Stolk, Donna Rowen, Barend Hout and Richard Norman
Additional contact information
Nancy J. Devlin: University of Melbourne
Tianxin Pan: University of Melbourne
Mark Sculpher: University of York
Mark Jit: London School of Hygiene and Tropical Medicine
Elly Stolk: EuroQol Research Foundation, Rotterdam
Donna Rowen: University of Sheffield
Barend Hout: University of Sheffield
Richard Norman: Curtin University

PharmacoEconomics, 2023, vol. 41, issue 10, No 1, 1165-1174

Abstract: Abstract Value sets for the EQ-5D-Y-3L published to date appear to have distinctive characteristics compared with value sets for corresponding adult instruments: in many cases, the value for the worst health state is higher and there are fewer values

Date: 2023
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://link.springer.com/10.1007/s40273-023-01300-8 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:41:y:2023:i:10:d:10.1007_s40273-023-01300-8

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-023-01300-8

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().